Despite these advancements, there remain significant gaps in our understanding, particularly regarding the role of less conventional alarmins like HMGB1, IL-1α, IL-36 and TL1A in asthma pathology, as well as genetic factors that predispose patients to respond to specific biologics. Here, HMGB1 is linked to asthma.